0 likes | 11 Vues
The global Brain Tumor Diagnosis & Therapeutics Market size is predicted to reach USD 1107.2 million with a CAGR of 7.8% by 2030.
E N D
Brain Tumor Diagnosis & Therapeutics Market The Global Brain Tumor Diagnosis & Therapeutics Market is predicted to reach USD 1107.2 million with a CAGR of 7.8% by 2030. Next Move Strategy Consulting
Agenda • Market Overview • Market Segmentation • Regional Analysis • Key Market Players • Key Highlights Next Move Strategy Consulting
Market Overview • Growth of abnormal cells, in or around the brain is called as brain tumor. Tumors directly destroy the healthy brain cells and also damage other parts of the brain by causing inflammation, brain swelling and pressure within the skull. • With growing population, large number of people are susceptible to neurological conditions. Increasing aging population and growing prevalence of brain cancer are the major factors driving the demand for brain tumor diagnosis and therapeutic alternatives. • High cost of treatment, and lack of skilled professionals are some of the factors that are likely to hinder the growth of brain tumor diagnosis and therapeutics market. • Major growth strategies adopted by the organizations and players in the brain tumor diagnosis and therapeutics market are research and development and product launches, geographical expansion, collaborations, mergers & acquisitions, and pricing strategies. Next Move Strategy Consulting
Market Segmentation • By Product • MRI • CT Scan • Tissue Sampling • PET-CT Scan • Cerebral Arteriogram • Lumbar Puncture • Molecular Testing • EEG • By Therapeutics • Surgery • Radiation Therapy • Chemotherapy • Immunotherapy • Targeted Therapy Next Move Strategy Consulting
Regional Analysis • North America • U.S • Canada • Mexico • Asia-Pacific • China • India • Japan • South Korea • Australia • Rest of Asia-Pacific • RoW • UAE • Saudi Arabia • South Africa • Brazil • Remaining Countries • Europe • The UK • Germany • France • Italy • Spain • Denmark • Netherlands • Finland • Sweden • Norway • Russia Next Move Strategy Consulting
Key Market Players • GE Healthcare • Hitachi, Ltd. • Philips Healthcare • Siemens Healthineers • Toshiba Corporation • Fujifilm Corporation • Novartis • Merck & Co., Inc. • Shimadzu Corporation • Carestream Health Next Move Strategy Consulting
Key Highlights • Therapeutic Innovations: Progress in treatments includes targeted therapies, immunotherapies, and novel drug delivery systems. These advancements offer more personalized and effective treatment options. • R&D Investments: Significant investments in research and development are accelerating the discovery of new treatments and diagnostic tools, improving patient outcomes. • Market Segmentation: The market is segmented by type of tumor, diagnostic method, therapy type, and geography, with specific growth patterns in different regions. • Challenges: Despite progress, challenges such as high treatment costs, limited availability of specialized treatments, and side effects persist. Next Move Strategy Consulting
THANK YOU Next Move Strategy Consulting Follow us www.nextmsc.com info@nextmsc.com +1-217-650-7991 Access Full Report - https://www.nextmsc.com/report/brain-tumor-diagnosis-and-therapeutics-market Next Move Strategy Consulting